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| INTRODUC TI ON
Nearly 240 million people are chronically infected with hepatitis B virus (HBV), 1 and more than 686 million deaths are reported due to hepatitis B-related cirrhosis and liver cancer every year. 2 In China, approximately 90 million people are infected with HBV each year and nearly 28 million require therapeutic intervention. 3 Interleukin-21 (IL-21) is a member of the interleukin-2 family, which is primarily secreted by activated CD4 + T cells and natural killer T cells. 4 IL-21 promotes the proliferation and differentiation of NK cells, T cells, and B cells; it also stimulates immunoglobulin production and induces apoptosis in both immune and nonimmune cells. 5 IL-21 binds to its receptor, IL-21R, which is preferentially expressed in T and B lymphocytes, NK cells, certain myeloid cells, and keratinocytes, but is absent in other tissues and solid tumors. IL-21
binding to the IL-21 receptor regulates the activation and proliferation of T, B, and NK cells by stimulating the JAK-STAT signaling pathway. 6 JAK3 and STAT3 are the two key proteins that are integral to the JAK/STAT signaling pathway. [7] [8] [9] The broad immunomodulatory activity of IL-21 is critical in chronic viral infections. 10 IL-21 promotes proliferation of Tfh and Th17 lymphocytes, enhances the cytotoxicity of CD8 + T cells and NK cells, and induces differentiation of the B lymphocytes into plasma cells. 11 Conversely, IL-21 inhibits dendritic cells, induces apoptosis of B cells and NK cells, and inhibits Treg cells. Based on these mechanisms, IL-21 regulates immune response to HBV. IL-21 also plays a key regulatory role in HBV infection pathogenesis. High serum IL-21 levels are associated with a high model for end-stage liver disease (MELD) score and mortality rates. 10 In the mouse model of HBV, IL-21 regulates specific CD8 + T-and B-lymphocyte responses that are crucial for the clearance of the viral antigens. 12 IL-21 also modulates CD4 + T-helper 2 (Th2) response that promotes HBV clearance and in vivo fibrogenesis. IL-21 is also involved in the development of severe liver inflammation. 13 Host genetic factors influence the extent of HBV-related liver injury, fibrosis, and tumorigenesis. 14 Therefore, designing effective therapeutic strategies against chronic HBV infection requires a better understanding of the host and viral mechanisms that affect HBV replication and persistence. IL-21 polymorphisms are associated with systemic lupus erythematosus, Graves' disease, ischemic stroke, chronic hepatitis B infection, breast cancer, and thyroid cancer. [15] [16] [17] [18] [19] [20] Moreover, polymorphisms in the IL21-JAK-STAT signaling pathway are associated with breast cancer, renal cell carcinoma, and chronic myelogenous leukemia. [21] [22] [23] IL-21 gene polymorphisms such as rs12508721 T/C and rs2221903 A/G are also recognized as risk factors for HBV-related HCC and chronic HBV infections. 24 In this study, we investigated the association of five SNPs in the IL21-JAK-STAT signaling pathway genes with HBV infection and related pathology. Signed informed consent forms were obtained from all the study subjects.
| MATERIAL S AND ME THODS

| Ethics statement
| Study subjects
We recruited 546 HBV patients that were diagnosed at the West We excluded individuals with a history of other infectious diseases such as HIV and syphilis and other complex health problems, such as cardiomyopathy, hypertension, or diabetes. We also enrolled 353 healthy subjects based on physical examination from the general population. Based on the HBV serological marker testing, the controls were divided into negative (253 cases) and anti-HBspositive (100 cases) subgroups.
| Selection of SNPs
We searched the dbSNP (http://www.ncbi.nlm.nih.gov/projects/ SNP/), miRBase registry (http://microrna.sanger.ac.uk), to identify SNPs in the IL-21, IL-21R, JAK3, and STAT3 genes with a minor allele 
| Genomic DNA extraction
We collected 5-10 mL peripheral blood sample with disposable syringes under aseptic conditions from each study subject. Then, genomic DNA was extracted from 200 μL of blood using the QIAamp® DNA Blood Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions. The DNA was quantified in each sample and then diluted to 10 ng/µL with AE buffer (10 mM Tris-Cl 0.5 mM EDTA; pH 9.0).
| Genotyping by HRM analysis
The PCR primers used to detect the five SNPs by the high-resolution melting (HRM) method are shown in Table 9 . The primers were de- 
| DNA sequencing
The genotypes of some samples were previously confirmed by sequencing the control samples of the five SNPs. The PCR products were purified using 1 unit of shrimp alkaline phosphatase. Then, the PCR samples were treated with shrimp alkaline phosphatase (SAP) and sequenced using the same forward primers for the five SNPs that were used for the PCR with the 
| Detection of the HBV serological markers
We collected 3 mL peripheral vein blood samples from patients into vacuum tubes containing heparin. After separating out the blood cells, we determined the HBV serological markers in the plasma: 
| RE SULTS
| Clinicopathological characteristics of study subjects and Hardy-Weinberg equilibrium (HWE) analysis
The basic clinicopathological features of both the patients and the healthy controls in different experimental groups are shown in Table 1 . There were no differences in the mean age and gender TA B L E 3 Comparison of genotype and allele frequencies between patient and control groups distributions between HBV-infected patients (P = 0.60), CHB patients (P = 0.44), HBV-related LC patients (P = 0.36), and HBV-related HCC patients (P = 0.08) with their corresponding controls. Table 2 summarizes the Hardy-Weinberg equilibrium (HWE) analyses for the genotypes of the five SNPs in all groups. In the controls, the genotype distributions of all five polymorphism loci were according to HWE (P > 0.05). However, in the HBV-infected patients, as well as the CHB and HBV-related HCC patient subgroups, IL-21R rs2285452 SNP showed deviation from HWE (P = 1.60e −6 , 0.002 and 1.94e −8 , respectively). Our findings support previous reports that suggest such deviations from HWE in the case group as a result of genetic drift influenced by the disease. 17,18
| Correlation between the gene polymorphisms and HBV infection
We genotyped five SNPs (IL-21 rs2221903, IL-21 rs4833837, IL-21R rs2285452, STAT3 rs1053023, and JAK3 rs3008) in the HBV-infected patients and control subjects. The distribution of genotypic and allelic frequencies of the five SNPs is summarized in Table 3 .
The genotype and allele frequencies were similar in the patient and control groups for IL-21 rs2221903 (P = 0.83 and 0.67, respectively; OR = 0.86, 95% CI = 0.40-1.82), IL-21 rs4833837 (P = 0.80 and 0.49, respectively; OR = 1.31, 95% CI = 0.61-2.77), IL-21R rs2285452 (P = 0.25 and 0.68, respectively; OR = 0.93, 95% CI = 0.68-1.29), STAT3 rs1053023 (P = 1.00 and 0.96, respectively; OR = 1.01, 95% CI = 0.77-1.31), and JAK3 rs3008 (P = 0.32 and 0.54, respectively; OR = 1.08, 95% CI = 0.85-1.37) polymorphisms. Moreover, there were no significant differences between the patient and controls groups in the additive, dominant, and recessive models for the five candidate SNPs as shown in Table 4 .
| Correlation between the gene polymorphisms and different HBV-related pathologies
Next, we investigated the correlation between the five SNPs and different HBV-related pathologies such as CHB, HBV-related LC, and HBV-related HCC (Tables 5-7 ). The allele and genotype distributions of the candidate five SNPs were similar in the CHB (Table 5 ) and the HBV-related LC ( Table 6 ) relative to the control groups. However, the AA, GA, and GG genotypes of IL-21R rs2285452 polymorphism were differently distributed between the HBV-related HCC and control groups (P = 0.007; Table 7 ). And the data for the subgroup analysis based on the different genetic models are shown in Table 8 .
In the recessive model, subjects carrying the IL-21R rs2285452 AA genotype were associated with greater risk (2.27-fold) in developing HBV-related HCC than the combined genotypes of GA and GG carriers (AA vs GA + GG; P = 0.03, OR = 3.27, 95% CI = 1. 16-9.20) .
However, the additive model analysis of the IL-21R rs2285452 SNP (AA vs GA vs GG; P = 0.97, OR = 1.00, 95% CI = 0.67-1.53) showed no differences for CHB and HBV-related LC subgroups vs control group (Table 9 ).
| Correlation analysis between the gene polymorphisms and the serological marker mode of HBV
The serological markers (HBsAg, anti-HBs Ab, HBeAg, anti-HBe Ab, and anti-HBc Ab) are used to estimate the progression and outcomes of HBV infection. Therefore, we tested the serological markers of 257 randomly selected CHB patients and analyzed the relationship between candidate SNP genotypes and the status of the serological markers (Table S1 ). We identified eight serological modes. The most represented serological mode in the HBV-infected patients was HBsAg+ HBeAg+ anti-HBc+ (n = 44.75%), followed by HBsAg+ anti-HBe+ anti-HBc+ (n = 37.35%), and HBsAg+ HBeAg+ anti-HBe+ anti-HBc+ (n = 8.2%). Among the 257 CHB patients, 139 (54.09%) were HBeAg+. As shown in Table S2 , the genotype and allele frequencies in the 8 serological marker modes were similar for IL-21 rs2221903 (P = 0.46 and 0.19, respectively), IL-21 rs4833837 (P = 0.36 and 0.21, respectively), STAT3 rs1053023 (P = 0.81 and 0.95, respectively), and JAK3 rs3008 (P = 0.79 and 0.94, respectively) SNPs. However, the distribution of the IL-21R rs2285452 alleles and genotypes showed significant differences among the eight serological marker modes (P = 0.00 and P = 0.00, respectively).
| D ISCUSS I ON
In our study, we examined the association of five SNPs in the IL-21-JAK-STAT signaling pathway genes (IL-21 rs2221903, IL-21 rs4833837, IL-21R rs2285452, STAT3 rs1053023, and JAK3 rs3008) with HBV infection-related pathogenesis in a Chinese population.
There was no significant association between HBV infection and all the five SNPs based on our analysis of the patient and control subjects. However, in the recessive model, the IL-21R rs2285452
AA genotype was associated with HBV-related HCC (P = 0.03). The subjects with the IL-21R rs2285452 AA genotype were at a higher risk (2.27 times) for HBV-related HCC than subjects with IL-21R rs2285452 GA/GG genotypes. This implied that IL-21R was a susceptibility gene associated with the occurrence and progression of HBV and that the patients with the heterozygous IL-21R rs2285452
AA genotype were at a greater risk of developing HCC.
IL-21 modulates both T-cell and B-cell responses, which are
critical in the immune response related to the pathogenesis of various diseases such as type 1 diabetes, autoimmune systemic lupus erythematosus (SLE), and multiple sclerosis, 26 including chronic HBV infections. 9, 18 Previous reports showed that SNPs in the IL-21
gene, such as rs907715 and rs2221903, increased susceptibility to
Grave's disease. 27 and systemic lupus erythematosus (SLE) in the Europeans and Americans, 28 as well as the Chinese. 29 Moreover, IL-21 rs4833837 SNP was identified as a protective factor for psoriasis. 9 Although most IL-21 gene-related SNPs were related to autoimmune diseases, the IL-21 rs2221903 genotype AG and allele G was identified as a protective factor against chronic HBV and the IL-21
rs2221903 genotype AA and allele A was identified as a risk factor in chronic HBV infections. 30 We postulate that IL-21 modulates B lymphocytes, which play a significant role in neutralizing and removing circulating HBV by producing effective antibodies. 31 In our study, the two SNPs in the IL-21 gene, rs2221903 and rs4833837, were located in the intron and the 3rd exon of the IL-21 gene, respectively.
However, they were not associated with HBV infection. Although
Li'reseach 30 and our study both chose Chinese population as study subjects, Li'reseach was on people in northern China, while ours was focused on people in western China and Li'reseach had a little bit larger than our sample sizes. The varying results between our study and others may be due to the differences in sample sizes and the study populations.
In the present study, we demonstrated that the IL-21R
rs2285452 SNP was associated with HBV-related HCC. The IL-21R rs2285452 polymorphism is located in the 3'-UTR. The patients with the AA genotype of IL-21R rs2285452 show higher risk of HBV-related HCC than those with the AG/GG genotype. In a previous study, the IL-21R rs2285452 polymorphism showed differential genotype distribution in Hashimoto's thyroiditis (HT) and control subjects. 32 Moreover, the IL-21 rs2221903 and IL-21R rs3093301 polymorphisms were associated with chronic HBV infection, an interactive role of IL21R rs3093301 CC with IL-21 rs2221903 in inducing the elevation of IL-21 and IgE production in the HBV patients, thereby suggesting that the SNPs in the IL-21
and IL-21R genes influence the susceptibility and persistence of HBV by affecting serum IL-21 and IgE levels. 30 Our finding suggests that the SNPs inIL-21R play an important role in HBV-related HCC. We postulate that IL-21 may be closely TA B L E 7 Comparison of genotype and allele frequencies between HBV-related HCC and control groups related to HBV-related HCC cells. 9, 18 On the other hand, IL-21 probably enhances the antibody-dependent cytotoxicity of NK cells.
IL-21 in combination with soluble programmed death receptor-1
(PD-1) stimulated different periods of B lymphocyte, T lymphocyte, and NK cell proliferation by IL-2, IFN-γ, whereas downregulation of IL-10 significantly inhibited tumor growth. 26 Furthermore, HBV infection promotes HCC, whereas activated CD4+ T lymphocytes and NK cells that produce IL-21 play a critical role in antitumor immunity. 31 Moreover, HBV infection suppresses NK cell proliferation, differentiation, or activation. 30 Although we did not find a difference, previous studies have shown that IL-21 and IL-21R play an im- 35 However, the relationship between STAT3 rs1053023 SNP and HBV is unclear. In our study, there was no association between HBV pathogenesis and STAT3 rs1053023 and JAK3 rs3008 SNPs. However, STAT3 promotes cell cycle progression and cell proliferation of hepatocytes in response to liver regeneration. 36, 37 TA B L E 8 Association between IL-21-JAK/STAT signaling pathway polymorphisms and the risk of infecting with hepatitis B virus between patient subgroups and control groups Hence, further studies are needed to explore the role of SNPs in the JAK-STAT pathway in susceptibility to infectious diseases.
The serological markers (HBsAg, anti-HBs Ab, HBeAg, anti-HBe Ab, and anti-HBc Ab) are closely associated with the diagnosis of HBV infection. 25 In general, they are used to determine whether a suspected individual is suffering from HBV infection and estimate the replication status of HBV. The serological markers showed variability probably due to individual variations. In our study, there was no association between the genotype and allele frequency of the five polymorphisms and the eight serological marker modes.
Although there was significant correlation between the serological marker modes and the distribution of the IL-21R rs2285452 genotypes and alleles (P = 0.00, P = 0.00, respectively), the findings need to be confirmed by larger sample sizes because insufficient sample size may have caused a bias. Moreover, IL-21 serum levels modulate
HBsAg seroconversion during treatment. 38 The main limitation of our study is the limited sample size. Hence, the functional consequences of the SNPs in the IL-21-JAK/STAT signaling pathway in HBV-related pathogenesis need to be confirmed by large-scale studies in the future.
In summary, our study demonstrates that the IL-21R rs2285452 AA genotype is a risk factor for HBV infections and HBV-related HCC. Our study suggests that SNPs in the IL21-JAK-STAT signaling pathway modulate host immune responses to HBV infection and influence HBV-related disease outcomes.
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